Skip Navigation


Carcinogenesis Advance Access originally published online on June 23, 2009
Carcinogenesis 2009 30(10):1651-1659; doi:10.1093/carcin/bgp156
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
30/10/1651    most recent
bgp156v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chiu, Y.-C.
Right arrow Articles by Tang, C.-H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiu, Y.-C.
Right arrow Articles by Tang, C.-H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Involvement of AdipoR receptor in adiponectin-induced motility and {alpha}2β1 integrin upregulation in human chondrosarcoma cells

Yung-Cheng Chiu1,2,3, Dong-Chen Shieh3, Kwok-Man Tong2, Chao-Ping Chen2, Kui-Chou Huang2, Po-Chun Chen4, Yi-Chin Fong5, Horng-Chang Hsu1,5 and Chih-Hsin Tang4,6,*

1 Graduate Institute of Clinical Medical Science, China Medical University, Taichung 404, Taiwan
2 Department of Orthopaedics, Taichung Veterans General Hospital, Taichung 407, Taiwan
3 Department of Nursing, Hungkuang University, Taichung 433, Taiwan
4 Department of Pharmacology, College of Medicine, No. 91, Hsueh-Shih Road, China Medical University, Taichung 404, Taiwan
5 Department of Orthopaedics, China Medical University Hospital, Taichung 404, Taiwan
6 Graduate Institute of Basic Medical Science, China Medical University, Taichung 404, Taiwan

* To whom correspondence should be addressed. Tel: +886 4 22053366 ext. 2228; Fax: +886 4 22053764; Email: chtang{at}mail.cmu.edu.tw

Chondrosarcoma is a type of highly malignant tumor with a capacity to invade locally and cause distant metastasis. Chondrosarcoma shows a predilection for metastasis to the lungs. Adiponectin is a protein hormone secreted predominantly by differentiated adipocytes and is involved in energy homeostasis. However, the effect of adiponectin on migration activity in human chondrosarcoma cells is mostly unknown. We found that adiponectin increased the migration and expression of {alpha}2β1 integrin in human chondrosarcoma cells. The protein and messenger RNA expression of adiponectin receptor (AdipoR1 and AdipoR2) in chondrosarcoma patients and chondrosarcoma cell lines were significantly higher than the normal cartilage. Moreover, primary chondrosarcoma and chondrosarcoma cell lines (SW1353 and JJ012) were more invasive than normal chondrocytes. Adiponectin-mediated migration and integrin expression was attenuated by 5'-adenosine monophosphate-activated protein kinase (AMPK) small interfering RNA and an AMPK inhibitor (Ara A and compound C). Activation of p38 and nuclear factor-kappa B (NF-{kappa}B) pathways after adiponectin treatment was demonstrated, and adiponectin-induced expression of integrins and migration activity was inhibited by the specific inhibitor and mutant of p38 and NF-{kappa}B cascades. This study showed for the first time that adiponectin mediates the migration of human chondrosarcoma cells. One mechanism underlying adiponectin-directed migration was transcriptional upregulation of {alpha}2β1 integrin and activation of AdipoR receptor, AMPK, p38 and NF-{kappa}B pathways.

Abbreviations: AMPK, 5'-adenosine monophosphate-activated protein kinase; DN, dominant negative; IKK, I{kappa}B{alpha} kinase; MMP, matrix metalloproteinase; mRNA, messenger RNA; NF-{kappa}B, nuclear factor-kappa B; PBS, phosphate-buffered saline; PDTC, pyrrolidine dithiocarbamate; qPCR, quantitative real-time polymerase chain reaction; siRNA, small interfering RNA; TPCK, N{alpha}-tosylphenylalanyl-chloromethyl-ketone

Received January 12, 2009; revised May 10, 2009; accepted June 16, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.